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membrane constituents and inhibits the P-gp
activity in rat hepatocytes
Ruizhi Zhao*, Lijuan Liu, Yinjie Wang and Zhicai XiaoAbstract
Background: Vinegar-baked Radix Bupleuri (VBRB) enhances the effects of other drugs on the liver by increasing
drug distribution to the liver, but the mechanism of action remains unclear. The present study was designed to
determine the effects of VBRB on the membrane permeability, constituents, and P-glycoprotein (P-gp) activity of
hepatocyte BRL cells, in order to interpret the liver targeting enhancing effects of VBRB.
Methods: The membrane permeability and P-gp expression were analyzed by flow cytometry. The membrane
constituents were determined by an automatic biochemistry analyzer and thin-layer chromatography.
Results: The results showed that, compared with the control, VBRB enhanced the membrane permeability by
41-67% (P < 0.05), which occurred in the absence of any cytotoxicity. VBRB had marginal effects on the cholesterol
content, but significantly affected the total protein contents and the lipid constituents of the cell membrane in a
dose- and time-dependent manner. VBRB inhibited P-gp expression in the cell membrane by 59-86% (P < 0.01).
Conclusion: VBRB affects the constituents of BRL cells and increases its permeability, which may help explain its
liver-targeting effects.
Keywords: Radix Bupleuri, P-gp, Phosphosphingolipid, Phosphatidylserine, Phosphatidylcholine, Phosphatidyl
ethanolamine, Vinegar, Membrane constituents, CholesterolBackground
Bupleurum Chinense DC (Bei Chai Hu, Radix Bupleuri)
has a wide spectrum of pharmacological effects [1-3],
and is a frequently used herb in China for treating vari-
ous diseases, such as fever, influenza, menstrual disorder,
jaundice, bitter taste in the mouth as well as hypochon-
driac pain and hepatitis. Vinegar-baked Radix Bupleuri
(VBRB) is the processed product of Radix Bupleuri with
vinegar and is commonly used for the treatment of liver
diseases such as jaundice and hepatitis [4]. However, the
mechanisms of action of VBRB are not fully understood.
Drug efficacy is primarily dependent on its concentra-
tion at the site of action. In our previous studies, resvera-
trol, rhein and oxymatrine were selected as model drugs
to investigate the effects of VBRB on drugs distribution.
Our results showed that VBRB increased the liver* Correspondence: 13610241754@163.com
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unless otherwise stated.distribution of resveratrol, rhein, and oxymatrine [5-7] in
experimental rats or mice, indicating that VBRB may en-
hance liver uptake or decrease the efflux of these drugs.
Drug distribution is often determined by the interactions
between drug and its microenvironment, including trans-
porters and the constituents of cell membrane. Therefore,
in the present study, the influence of VBRB on the perme-
ability of the cell membrane of normal rat liver cell line
BRL was investigated. Furthermore, the effects of VBRB
on membrane components and P-glycoprotein (P-gp) ex-
pression were analyzed. These results are beneficial to the
rational use of VBRB to improve its clinical efficacy. .Methods
Chemicals
VBRB [Radix of Bupleurum Chinense DC, baked with 20%
vinegar, or as cited as B Chinese in the Pharmacopeia of
China (Bei Chai Hu)] was purchased from Kangmei Med-
ical Company (Guangzhou, China), and was produced intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sample was authenticated and voucher specimens were
deposited in the Department of Pharmacognosy and
Phytochemistry, Guangzhou University of Chinese Medi-
cine. Dextran labeled with fluorescein isothiocyanate (FD-
500S), 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT), Dimethyl sulfoxide (DMSO), N-2-
Hydroxyethylpiperazine -N—2- ethanesulfonic acid (HEPES),
phenylmethylsulfonyl fluoride (PMSF), Tris, penicillin, and
streptomycin were purchased from Sigma-Aldrich (St.
Louis, MO, USA). Dulbecco’s modified Eagle’s medium
(DMEM) in high glucose, 0.25% pancreatin, and new-born
calf serum were purchased from Gibco Company (Grand
Island, USA). Phosphate buffered saline (PBS) was pur-
chased from Dingguo Biology and Technology Company
(Beijing, China). Phosphosphingolipid (SM, 98%), phos-
phatidylserine (PS, 98%), phosphatidylcholine (PC, 98%),
and phosphatidyl ethanolamine (PE, 98%) were obtained
from LARODAN (Malmo, Sweden). Prefabricated plates
were obtained from Merck (Darmstadt, Germany). CD 243
was purchased from Beckman Coulter (Fullerton, USA).
Extraction of VBRB
The extraction of VBRB was carried out according to the
method reported previously [5]. Briefly, 50 g of VBRB was
soaked in 500 mL of water for 0.5 h, heated to boiling
point, and kept boiling for 45 min, and then filtered. The
herbs were extracted again with 400 mL of water using
the above procedure. The pooled filtrates were condensed
to 100 mL by rotary evaporation at 70°C, and then stored
at −20°C until use. The percent was based on the dry
weight of polysaccharides or saponin in the total weight of
VBRB and was determined in our laboratory. There were
about 4.5% of high molecular weight polysaccharides,
3.5% of low molecular weight polysaccharides, and 1% of
sum-saponin and sapogenin in VBRB. The concentrations
of saikosides were determined by HPLC-MS in our labora-
tory and the contents of Saikoside a, b, c, d in the extract
were 44.45, 79.3, 10.6, and 43.3 mg, respectively.
Cell line and culture
Normal rat hepatocyte cell line BRL was purchased from
the Cell Research Center of Chinese Academy of Science
(Shanghai, China). The cells were maintained with DMEM
containing 10% new-born calf serum, 0.25% pancreatic en-
zyme (Gibco, Grand Island, USA), 100 ng/mL of penicillin,
and 100 ng/mL of streptomycin at 37°C in a humidified at-
mosphere containing 5% CO2.
Cell viability assay
BRL Cells were seeded onto 96-well plates at a density of
2 × 105 cells/mL. After incubation for 24 h at 37°C and 5%
CO2, 150 μL of VBRB solution at different concentrations
(0.16, 0.8, 4.0, 20, and 100 mg/mL) was added and co-cultured for 24 h; and then 20 μl of MTT solution (5 mg/
ml) was added into each well and incubated at 37°C for
4 h. Then the supernatant was removed and 150 μl of
DMSO was added to solubilize the formazan products.
Absorbance was measured at the wavelength of 570 nm.
The control wells were designated as 100% viability. The
blank values, indicating the absorbance of MTT and
DMSO only, were subtracted from all the samples.
Membrane permeability study
Viable BRL cells (2 × 105/mL) were washed with PBS twice,
suspended in Gibco RPMI 1640 (Gibco, Grand Island,
USA) and incubated in 6-well plates. After a 24-h incuba-
tion, VBRB at various concentrations (0, 0.4, 2, and 10 mg/
mL) was added and co-cultured. After 3 and 6 h of co-
culture, cells were washed with PBS twice. Then, DMEM
containing 10% new-born calf serum and 20 μl (5 mg/mL)
FD-500S was added and cultured for 2 h, thereafter, 0.25%
pancreatic enzyme was added, followed by trypsinization.
The cell suspension was then centrifuged at 109 g for
5 min. Fluorescence staining of the positive cells (FD-500S
taken up by cells) was quantified by flow cytometry (Elite
Beckman coulter, Fullerton, USA) with emission and excita-
tion wavelengths of 520 nm and 480 nm, respectively.
10,000 cells in each sample were counted and the percent-
age of positive cells was calculated.
Determination of the constituents of the BRL membrane
Cell membrane extraction was carried out according to
the methods reported previously [8]. In short, a cell sus-
pension was prepared in a 75-cm2 flask, to which the
VBRB extract at three different concentrations as afore-
mentioned was added after cells were cultured for 24 h.
After a 3- or 6-h culture with VBRB, the cells were washed
twice with PBS and then suspended in 5 mL of 4°C HEPES
buffer (1.2096 g/L) containing 0.1932 g/L MgCl2 and
0.0978 g/L PMSF. The cell suspension was then sonicated
and centrifuged at 109 g for 10 min. The supernatant was
further centrifuged at 12,000 g; the residue was resus-
pended in Tris–HCl (20 mM) buffer containing EDTA
(1 mM) and PMSF (1 mM). The suspension-centrifugation
procedure was then repeated an additional three times; the
entire procedure was performed at 4°C. The final residue
was used for subsequent analysis.
Determination of total protein and cholesterol
The above mentioned residue was divided into two
parts. Part I was dissolved in 1 mL of HEPES buffer for
total protein analysis and Part II was dissolved in 1 mL
of dehydrated alcohol for cholesterol determination.
Both samples were centrifuged at 1760 g for 10 min,
and the supernatant was collected and used for analysis
































































Figure 2 Effect of VBRB on viability of BRL cells.
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The total lipids were the sum of typical lipids that were
determined by the HPTLC scanning method [11], and
then the sum of the four lipids was calculated accordingly.
In brief, according to the method reported by Ismaili et al.
[11], thin-layer chromatography was used for the deter-
mination of membrane lipids. Residue prepared above was
dissolved in 1 mL of ethanol for analysis. The standard so-
lutions of phosphosphingolipid (SM), phosphatidylcholine
(PC), phosphatidyl ethanolamine (PE) and phosphatidyl-
serine (PS) were prepared at concentrations 5, 10, 10 and
25 mg/mL, respectively, and sample solutions were spot-
ted on a plate (Merck, Germany). The spotting volume
was 5 μL for samples and 1 or 4 μL for standard solutions.
Afterwards, the plate was developed in an automatic de-
veloping chamber (Camag, Switzerland) at 25°C with 75%
humidity and a developing distance of 8 cm. The deve-
lopment solution was chloroform-methanol-acetic acid-
water (10:2:1:0.25). After development, the plate was dried
and placed in a chamber of iodine vapor for 5 min. Finally,
the plate was covered with a blank plate and scanned at
380 nm with a Shimadzu (Japan) CS-9301 densitometric
scanner, using the software provided with the instrument,
and the peak areas were recorded. The peak areas ob-
tained from the standard solution were plotted against the
quality of the four components to produce separate work-
ing calibration plots for each compound. The amounts of
each lipid in the samples were then calculated by use of
the respective calibration plots.
P-gp expression determination
After a 3- or 6-h culture with various concentrations of
VBRB as noted above, the cells were washed twice with
PBS and then suspended in 500 μL PBS. Afterwards,
20 μL of fluorescein for labeling P-gp (CD 243) was added.
After a 15-min incubation, the free CD 243 was washed
with 1 mL PBS and the fluorescein stain ratio determined
by a flow cytometry (Elite Beckman coulter, USA) using
emission and excitation wavelengths of 520 nm and
480 nm, respectively.
Statistical analysis
The data are presented as the mean and standard devi-
ation (X ± S). All statistical analyses were performed using
SPSS 11.0 for Windows. The differences among various
treatments were analyzed by ANOVA using log X and Q
test for statistical analyses. P < 0.05 was regarded as statis-
tically significant.
Results
VBRB increases cell membrane permeability
As shown in Figure 1, almost all of the VBRB groups
showed significantly increased membrane permeability
in BRL cells, compared with control. The increasedpermeability values were between 41%-67%, except for the
lowest concentration group after a 3-h culture. As the cul-
ture time prolonged, the permeability increased signifi-
cantly (P < 0.05); the permeability at 24 h was 1.5 times
higher than that of the control group (data not shown). A
concentration-dependent increase in permeability was also
observed after a 3-h culture (P < 0.05); however, no signifi-
cant difference was found among the different VBRB
groups after a 6-h culture.Cell viability
Considering that an increase in cell membrane permeabil-
ity may be related to drug toxicity, several concentrations
of VBRB were used in our cell viability study in order to
determine if the increase in membrane permeability is due
to the toxicity of VBRB. As shown in Figure 2, VBRB
inhibited cell proliferation significantly when the VBRB
concentration was higher than 20 mg/mL; however, when
VBRB concentration was lower than 10 mg/mL, VBRB
had a marginal effect on cell viability, indicating that in-
creased permeability was not induced by a broken cell
membrane.
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Changes in cell membrane constituents may affect per-
meability. Therefore, the effects of VBRB on membrane
constituents were studied. As shown in Figure 3, the
total cholesterol content remained stable in the control
cells, and VBRB had marginal effects on total cholesterol
content.
VBRB has effects on total protein contents in a time-
dependent manner
Unlike total cholesterol, VBRB affected the total protein
contents in a time-dependent manner. After a 3-h cul-
ture, the medium and high concentrations of VBRB, but
not the low concentration, decreased total protein sig-
nificantly (P < 0.05). The decreased total protein extent
was 50% and 44% for the medium and high VBRB doses,
respectively. After a 6-h culture, all three concentrations
of VBRB showed marginal effects on protein contents
(Figure 3).
VBRB has significant effects on membrane lipids
The analytical method for lipids was validated by deter-
mining the specificity, linearity, accuracy, precision, and
stability. All four lipids (SM, PS, PC and PE) were sepa-
rated well in the given analytical conditions and a good
linearity was shown for each of the lipids. The calibration
curves for SM, PS, PC and PE were Y = 216.0X-49.19
(R2 = 0.993), Y = 223.4X + 19.38 (R2 = 0.995), Y = 127.6X +
47.68 (R2 = 0.991), and Y = 88.49X + 67.97 (R2 = 0.995), re-
spectively. The detection limits for SM, PS, PC and PE
were 2.5, 5, 5, 12.5 μg, respectively, and the linear range
was 2.5-30, 5–60, 5–60, 12.5-150 μg, respectively. The
spots were stable between 0.5-3 h with the SD being below
4.5% and the RSDs of precision and accuracy below 3.4%
and 3.7%, respectively.
The sum of the four lipids (SM, PS, PC and PE) was



















Figure 3 Effect of VBRB on the contents of total protein and cholesteVBRB on the total lipids were dependent on culture time
and VBRB concentration (Figure 4). At low concentra-
tion, VBRB increased the total lipids at both 3- and 6-h
culture times; at the medium and high concentration,
VBRB decreased the total lipids content at the 3-h cul-
ture time point, but increased the total lipids content at
6-h culture time significantly (P < 0.05).
We further examined four major types of lipids in BRL
cells after VBRB treatment and found that the specific lipid
contents were affected in a type-of-lipids-, culture time-,
and VBRB concentration-dependent manner (Figure 5). At
3 h after culture, the medium and high concentrations of
VBRB decreased the contents of all the four lipids signifi-
cantly (P < 0.05). In contrast, at low concentration, VBRB
decreased the content of PS, but increased the contents of
SM and PC significantly (P < 0.05). However, after a 6-h
culture the low concentration of VBRB decreased the
content of SM but increased the content of PS signifi-
cantly (P < 0.05). The medium and high concentrations
of VBRB increased the contents of all the four lipids sig-
nificantly, except for the medium concentration of VBRB,
which decreased the PE content significantly (P < 0.05).
VBRB inhibits P-gp expression
P-gp is a transporter in the cell membrane and is re-
sponsible for the efflux of substrates of the Pgp, which is
a key factor affecting the retention of many drugs in the
cell. Therefore, we studied the effects of VBRB on P-gp
expression. As shown in Figure 6, VBRB inhibited P-gp
expression significantly at all the time points (P < 0.01);
and the low concentration of VBRB had stronger effects
than high concentrations. This result was in accordance
with a previous study by Zhu et al., which reported that
Radix Bupleuri increases the cell concentration of vin-
cristine significantly, indicating that Radix Bupleuri











































Figure 4 Effect of VBRB on the total lipids.
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The action of drugs is often determined by the drug’s
concentration at target sites such as organs and cells;
and drug concentration in cells is a balance of uptake
and efflux. Drugs uptake or efflux by cells are deter-
mined by many factors, such as the drug’s molecular
size, polarity, charge, and, more importantly, its affinity
to the cell membrane [13]. Usually, small molecules with
good affinity to the cell membrane can be taken up or
efflux out by diffusion; however, only very few molecules
are transported through cells by this way. Most mole-
cules utilize a transporter-mediated mechanism. The ac-
tivity of transporters is affected by many factors, such as
the amount and stereo-chemical structure of the pro-





























Figure 5 Effect of VBRB on specific lipid contents.cholesterol around it [14,15]. The first sign reflecting the
drug-induced changes in membrane microenvironment
may be the changes in cell permeability. Therefore, in
the present study, we first determined the effects of
VBRB on cell permeability and found that VBRB en-
hanced the permeability of BRL cells significantly.
There are two types of hypotheses for the possible
mechanism of increased permeability; one is aqueous pore
formation and the other is a carrier-related mechanism
[16]. In the former case, low molecular weight substances
can get into cells easily and lead to membrane disruption
and cell death. In the latter case, although cell membrane
permeability is increased, cells are alive. In order to rule
out that the membrane permeability is induced by drug
toxicity, the effects of VBRB on the cell viability of BRL6h
2mg/mLVBRB 10mg/mLVBRB






































Figure 6 Effect of VBRB on P-gp expression in BRL cells.
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tions. The results indicated that, at the concentrations used
in the permeability study, VBRB had no or marginal effects
on cell viability. Therefore, the increased permeability
caused by VBRB was not due to aqueous pore formation
and was most likely due to a carrier-dependent mechan-
ism. Carriers are usually proteins; their activity is affected
by protein content and its microenvironment, such as the
contents of lipids and cholesterol [14,15]. Therefore, the
effects of VBRB on membrane constituents were further
studied in the subsequent experiments.
Cholesterol is the skeleton of the cell membrane; de-
creasing the cholesterol content usually induces cell
death [17]. Our results indicate that VBRB had a mar-
ginal influence on the content of cholesterol, indicating
that VBRB at the test doses in this study does not affect
the major cell membrane structure, which is helpful to
maintain cell integrity.
Proteins are the major components of channels and
transporters and their contents are an index of transporter
activity. Our results indicate that VBRB decreased total pro-
tein content after a 3-h culture and had a marginal effect
after a 6-h culture, implying that the effects of VBRB on
protein content may be transient. Since total protein levels
contain all kinds of membrane proteins, including two con-
trary direction transporters, uptake and efflux transporters,
total protein levels may not be a good indicator for trans-
porter studies such as the present study. The uptake trans-
porters include organic anion transporting polypeptides,
organic anion transporters, and organic cation transporters;
the efflux pumps consist of P-gp, multidrug resistance-
associated protein family, bile salt export pump, breast can-
cer resistance protein, and others. Therefore, further study
of VBRB effects on specific protein content is essential.Total lipid content reflects the polarity of the cell and
is also a key element determining drug-membrane affin-
ity and drug distribution. When total lipid content is in-
creased, the polarity of the cell membrane is decreased;
low polarity drugs such as resveratrol and rhein may
then get into liver cells easily. When lipid content is de-
creased, the membrane polarity is increased and drugs
with higher polarity may have a better affinity.
Besides polarity, the membrane lipids specifically or
non-specifically interact with membrane proteins, affect-
ing both the partitioning and folding of the protein and
its function [15]. Some lipids may be incorporated into
transporters and are necessary for the activity of trans-
porters [18,19]. Furthermore, all lipids are substrates of
ATP-dependent ATP-binding cassette (ABC) transloca-
tors [20]. ABC transporters regulate the efflux and redis-
tribution of lipids and, in turn, lipid composition can
control ABC activity. This is proven by many studies
[21-24]. Since there are many kinds of transporters in
hepatocytes and the total drug uptake is the combined
effect of all related factors, the effects of single specific
lipids on the activity of given transporters needs to be
further investigated.
A decrease in efflux activity is one of the major rea-
sons for increased permeability. The results of this study
show that VBRB inhibited the activity of P-gp signifi-
cantly, indicating a prolonged retention time of drugs in
the liver, which is in agreement with our previous results
that VBRB decreases the clearance of the test com-
pounds from the liver [5-7].
In traditional Chinese medicine, site-directed drug ef-
fects can be achieved by co-administration of therapeutic
drugs with organ-targeting agents, leading to either sy-
nergistic or attenuation effects [4]. This phenomenon is
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meridian guide drugs for liver targeting, which can en-
hance the effects of other drugs on the liver [7]. Our previ-
ous study shows that this liver enhancing effect of VBRB
is due to its effect on distribution of other drugs in the
liver [5-7]. The present study first revealed that VBRB af-
fected the microenvironment of the cell, which may be re-
sponsible for its site-directed effects.
Conclusion
In the present study, we demonstrated that VBRB affected
the permeability of cultured BRL cells in a time-dependent
manner, which was not due to a broken membrane. More-
over, the effects of VBRB on membrane constituents were
dependent on VBRB dose, action time and membrane
constituent type. VBRB affected the contents of lipids and
protein, but not cholesterol. VBRB inhibited P-gp expres-
sion significantly. In summary, affecting lipid contents and
inhibiting P-gp expression are possible mechanisms for
the enhanced liver targeting effects of VBRB, and close at-
tention to drug-drug interactions should be paid when co-
administering drugs with VBRB in the clinic.
Abbreviations
VBRB: Vinegar-baked Radix Bupleuri; P-gp: P-glycoprotein;
SM: Phosphosphingolipid; PC: Phosphatidylcholine; PE: Phosphatidyl
ethanolamine; PS: Phosphatidylserine.
Competing interests
The authors declare that they have no competing interest.
Authors’ contributions
RZ conceived of the study, and participated in its design, LL carried out the
permeability study, the membrane constituents determine and P-gp activity,
and YW and ZX performed the statistical analysis. All authors read and
approved the final manuscript.
Acknowledgements
This study was supported by the National Natural Science Foundation of
China (Grant No. 30672668 and 81073063).
Received: 22 June 2014 Accepted: 22 September 2014
Published: 25 September 2014
References
1. Tsai YJ, Chen IL, Horng LY, Wu RT: Induction of Differentiation in Rat C6
Glioma Cells with Saikosaponins. Phytother Res 2002, 16:117–121.
2. Cheng PW, Chiang LC, Yen MH, Lin CC: Bupleurum kaoi inhibits Coxsackie
B virus type 1 infection of CCFS-1 cells by induction of type I interferons
expression. Food Chem Toxicol 2007, 45:24–31.
3. Cheng YL, Chang WL, Lee SC, Liu YG, Chen CJ, Yu DS, Lin SZ, Harn HJ:
Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of
A549 human lung cancer cells via inducing apoptosis and suppressing
telomerase activity. Life Sci 2003, 73:2383–2394.
4. Zhao RZ, Liu SJ: TCM medicinal guide theory and target-tropism
administration. Zhong Yi Za Zhi 2005, 46:643–645. Chinese.
5. Zhao RZ, Liu SJ, Mao SR, Wang YJ: Study on liver targeting effect of
vinegar-baked Radix Bupleuri on resveratrol in mice. J Ethnopharmacol
2009, 126:415–420.
6. Zhao RZ, Yuan D, Liu SJ, Chen YJ, Liu LJ, Zhao Y: Liver targeting effect of
vinegar-baked Radix Bupleuri on rhein in rats. J Ethnopharmacol 2010,
132:421–428.7. Zhao RZ: Target delivery of Traditional Chinese medicine. In Recent
Advance in Theories and Practice of Chinese Medicine. Edited by Kaixue K.
Croatia: Intech; 2011:313–336.
8. Steck T: The organization of proteins in the human red blood cell
membrane. J Cell Biol 1974, 62:1–19.
9. Beaufay H, Amar-costesec A, Feytmans E, Thinès-Sempoux D, Wibo M, Robbi
M, Berthet J: Analytical study of microsomes and isolated subcellular
membranes from rat liver. J Cell Biol 1974, 61:188–200.
10. Nomiyama K, Nomiyama H, Liu SJ, Tao YX, Nomiyama T, Omae K: Lead
induced increase of blood pressure in female lead workers.
Occup Environ Med 2002, 59:734–739.
11. Ismaili A, Meddings JB, Ratnam S, Sherman PM: Modulation of hostcell
membrane fluidity:a novel mechanism for preventing bacterial adhesion.
Am J Physiol 1999, 277:G201–G208.
12. Zhu JQ, Han XH, Xue YJ: Effects of the Extracts from BCDC on Cellular
VCR Concentration of Human Hepatoma BEL–7402 Cells. Beihua Daxue
Xuebao (Ziran Kexueban) 2005, 6:62–64. Chinese.
13. Burton PS, Goodwin JT, Widmar TJ, Amore BM: Predicting drug absorption:
how nature made it a difficult problem. J Pharmacol Exp Ther 2002,
303:889–895.
14. Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle.
Science 2009, 327:46–50.
15. Tillman TS, Cascio M: Effects of membrane lipids on Ion channel structure
and function. Cell Biochem and Biophys 2003, 38:161–190.
16. Rokitskaya TI, Kolodkin NI, Kotova EA, Antonenko YN: Indolicidin action on
membrane permeability: carrier mechanism versus pore formation.
Biochim Biophys Acta 1808, 2011:91–97.
17. Hao M, Mukherjee S, Maxfield FR: Cholesterol depletion induces large
scale domain segregation in living cell membranes. Proc Natl Acad Sci
U S A 2001, 98:13072–13077.
18. Ferté J: Analysis of the tangled relationships between P-glycoprotein-
mediated multidrug resistance and the lipid phase of the cell
membrane. Eur J Biochem 2000, 267:277–294.
19. Kim KH, Ahn T, Yun CH: Membrane properties induced by anionic
phospholipids and phosphatidylethanolamine are critical for the
membrane binding and catalytic activity of human cytochrome P450
3A4. Biochemistry 2003, 42:15377–15387.
20. Quazi F, Molday RS: Lipid transport by mammalian ABC proteins. Essays in
Biochem 2011, 50:265–290.
21. Tarling EJ, Vallim TQ, Edwards PA: Role of ABC transporters in lipid
transport and human disease. Trends Endocrinol Metab 2013,
doi: 10.1016/j.tem.2013.01.006.
22. Vedhachalam C, Duong PT, Nickel M, Nguyen D, Dhanasekaran P, Saito H,
Rothblat GH, Lund-katz S, Phillips MC: Mechanism of ATP-binding cassette
transporter Al-mediated lipid efflux to apolipoprotein A-1 and formation
of high density lipoprotein particles. J Biol Chem 2007, 282:25123–25130.
23. Ecker GF, Stockner T, Chiba P: Computational models for prediction of
interactions with ABC-transporters. Drug Discov Today 2008, 13:311–317.
24. Jones PM, George AM: Mechanism of the ABC transporter ATPase
domains: catalytic models and the biochemical and biophysical record.
Crit Rev Biochem Mol Biol 2013, 48:3950.
doi:10.1186/1472-6882-14-357
Cite this article as: Zhao et al.: Vinegar-baked Radix Bupleuri modulates
the cell membrane constituents and inhibits the P-gp activity in rat
hepatocytes. BMC Complementary and Alternative Medicine 2014 14:357.
